Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

By sjmartinez • September 18, 2024

Bardia A, Hu X, Dent R, Yonemori K, Barrios CH, O'Shaughnessy JA, Wildiers H, Pierga JY, Zhang Q, Saura C, Biganzoli L, Sohn J, Im SA, Lévy C, Jacot W, Begbie N, Ke J, Patel G, Curigliano G; DESTINY-Breast06 Trial Investigators. Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer. N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMoa2407086. Epub ahead of print. PMID: 39282896.

Tags: Hematology/Oncology, Publications

Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma

Mar N, Cabral MY, Go J, Kaakour D, Dwabe S, Seyedin SN, Drakaki A. Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without[...]

A Case of Gastrointestinal Krukenberg Tumor Initially Suspected as Primary Ovarian Cancer and the Implications for Management

Sidhu N, Le BM, Doan EL, Dao KT, Montana W. A Case of Gastrointestinal Krukenberg Tumor Initially Suspected as Primary Ovarian Cancer and the Implications[...]

Choreiform Movements and Pachymeningeal Enhancement in an Elderly Patient With Abnormal Blood Counts: A Case Report and Review of Literature

Bondariyan N, Patel M, Shah P, Park D, Dermarderosian A, Arfaie S, Mashayekhi M, Dashtipour K, Akhtari M. Choreiform Movements and Pachymeningeal Enhancement in an[...]